Implementation of ACT Through Facebook for Teenagers With Asthma

NCT01675921 | Completed

• 1 other identifier: 2012-P-000674/1
• Study Type: interventional
• Target: 120
• Locations: 1 country
• Sites: 1

Brief Summary

The investigators hypothesize that at the end of the 12-month trial, teenagers regularly self-monitoring their asthma control with ACT administered through Facebook will have improved ACT scores as compared with teenagers receiving usual care.

Conditions

Asthma

Keywords

Asthma; Facebook; teenagers; ACT

Outcome Measures

Primary Outcomes (1)

• Asthma Control Test (ACT) scores

  Assess the effect of the Facebook intervention (also referred to as "Connect 2 My ACT" intervention on trends of ACT scores in teenagers diagnosed with asthma

  0 to 12 months

Secondary Outcomes (6)

• Emergency Department (ED) visits and Hospital Admissions

  0 to 12 months

• Engagement

  0 to 12 months

• Provider engagement

  0 to 12 months

• Patient engagement and Emergency Department (ED) visits

  0 to12 months

• Satisfaction with intervention

  at 12 months

Study Arms (2)

Control

NO INTERVENTION

Participants will continue to receive medical care from their doctor as usual. Participants will have access to this study website at the start and at the end of the study.

Facebook group

EXPERIMENTAL

Participants will continue to receive medical care from their doctor as usual. Participants will have access to the study website at all times throughout the study. Participants will have access to the secret study group on Facebook for 12 months. Participants will take the ACT survey once a month for 12 months.

Other: Facebook group

Interventions

Facebook group OTHER

Facebook will be used to remind participants to take the ACT survey once every month for 12 months.

Facebook group

Eligibility Criteria

• Age: 14 Years - 17 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17)

You may qualify if:

• Teenagers age 14-17 years inclusive.
• Diagnosis of asthma by a PCP or a specialist at a Partners affiliated hospital/health center.
• Access to computer with internet.
• Active email account
• Fluency in English (spoken and written)
• Be on controller medications (such as: inhaled corticosteroids, cromolyn sodium and nedocromil sodium, long-acting beta-agonists (LABAs), and methylxanthines) to control asthma and prevent symptoms from developing.
• Have an active account on Facebook

You may not qualify if:

• Disability or co-morbidity precluding regular access to the internet.
• Cognitive impairment.

Sponsors & Collaborators

• Massachusetts General Hospital: lead

Study Sites (1)

Partners Center for Connected Health

Boston, Massachusetts, 02114, United States

Location

MeSH Terms

Conditions

Asthma

Condition Hierarchy (Ancestors)

Bronchial Diseases; Respiratory Tract Diseases; Lung Diseases, Obstructive; Lung Diseases; Respiratory Hypersensitivity; Hypersensitivity, Immediate; Hypersensitivity; Immune System Diseases

Study Officials

• Kamal Jethwani, MD, MPH

  Partners Healthcare, Center for Connected Health

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: HEALTH SERVICES RESEARCH
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Dermatologist

Study Record Dates

• First Submitted: August 28, 2012
• First Posted: August 30, 2012
• Study Start: September 1, 2012
• Primary Completion: February 1, 2015
• Study Completion: April 1, 2015
• Last Updated: September 1, 2020

Record last verified: 2020-08

Locations

US (1)